Renalis, a digital health startup based in Cleveland, has closed an $824,000 funding round led by the Healthcare Collaboration Fund.
The funding, which included participation from JumpStart Inc., the Cleveland-based venture developer, will be used to amplify research, support regulatory efforts and build a team to lead commercialization and technology efforts, the company said in a press release.
Formerly based in Chicago, Renalis is developing digital therapeutics to treat pelvic health disorders such as overactive bladder, according to the company's website.
The company's first digital therapeutic product, CeCe, enables patients to record and manage symptoms of overactive bladder via a mobile application.
"We can now accelerate our go-to-market plan to deliver evidence-based solutions to chronic, expensive and prevalent conditions like (overactive bladder) to millions of patients in the U.S. and beyond," said Missy Lavender, CEO of Renalis, in the release.
"Renalis in tackling a significant unmet need in pelvic health management," said Hardik Desai, senior investing partner at JumpStart, in the release.
The Healthcare Collaboration Fund is managed by a partnership between JumpStart and University Hospitals Ventures, the innovation and commercialization arm of University Hospitals, in Cleveland.
"Our investment enables UH to be (a) 'living laboratory' so that we can prove out Renalis' novel approach and have an even bigger impact on patient care," said Neil Wyant, managing director of UH Ventures, in the release.
